Processing

Please wait...

Settings

Settings

Goto Application

1. WO2004023979 - MUCUS FORMULATION FOR MUCOSAL SURFACES AND USES THEREOF

Publication Number WO/2004/023979
Publication Date 25.03.2004
International Application No. PCT/US2003/028582
International Filing Date 12.09.2003
IPC
A61K 9/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
CPC
A61K 31/085
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
075Ethers or acetals
085having an ether linkage to aromatic ring nuclear carbon
A61K 31/19
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
19Carboxylic acids, e.g. valproic acid
A61K 31/4178
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
41641,3-Diazoles
4178not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
A61K 31/573
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
57substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
573substituted in position 21, e.g. cortisone, dexamethasone, prednisone ; or aldosterone
A61K 31/70
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
A61K 45/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Applicants
  • BIOSYN, INC. [US]/[US] (AllExceptUS)
  • BURRUANO, Brid [US]/[US] (UsOnly)
  • SCHNAARE, Roger, L. [US]/[US] (UsOnly)
Inventors
  • BURRUANO, Brid
  • SCHNAARE, Roger, L.
Agents
  • ZISKA, Suzanne, E.
Priority Data
60/409,98312.09.2002US
60/458,94901.04.2003US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) MUCUS FORMULATION FOR MUCOSAL SURFACES AND USES THEREOF
(FR) FORMULATION DE MUCUS POUR SURFACES DE MUQUEUSES ET UTILISATIONS ASSOCIEES
Abstract
(EN)
The present invention includes formulations comprising synthetic vaginal fluid, synthetic cervical mucus, and, a mixture of a synthetic cervical mucus and synthetic vaginal fluid suitable for mucosal administration of at least one therapeutic agent. The formulations of the invention are useful in the treatment, prevention and control of diseases and conditions in a subject in need thereof. The present invention also includes methods of administering the formulations. Also included are methods of using the formulations in the treatment, prevention and control of diseases or conditions affecting other mucus membranes, such as the nose, throat and gastrointestinal tract.
(FR)
L'invention concerne des formulations, comprenant du liquide synthétique vaginal, de la glaire cervicale synthétique et un mélange de glaire cervicale synthétique et de liquide synthétique vaginal, adaptées à administrer au moins un principe actif thérapeutique à des muqueuses. Les formulations de l'invention sont utiles dans le traitement, la prévention et de lutte contre des maladies et des troubles expérimentés par un sujet. L'invention concerne aussi des méthodes d'administration des formulations. Elle concerne enfin des méthodes d'utilisation des formulations dans le traitement, la prévention et la lutte contre des maladies et des troubles affectant d'autres membranes de muqueuses telles que le nez, la gorge et le tractus gastro-intestinal.
Also published as
Latest bibliographic data on file with the International Bureau